4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-035394
President & CEO sold 80,000 shares at $9.12 ($729,600)
- President & CEO acquired 80,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Stonehouse Jon P · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-12-03 | Exercise or conversion : show line 1 in the form | +80,000 | $1.20 | $96,000 | 807,674 | D |
| 2018-12-03 | Sale : show line 2 in the form | −80,000 | $9.12 | $729,600 | 727,674 | D |
| Open-market sales · 80,000 sh · avg $9.12 · $729,600 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-12-03 | Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) | −80,000 | 0 | D |
Loading xslF345X03/form4.xml…